Literature DB >> 23159295

Serum carcinoembryonic antigen level is associated with arterial stiffness in healthy Korean adult.

Urhee Bae1, Jae Yong Shim, Hye Ree Lee, Jin Young Shin.   

Abstract

BACKGROUND: Carcinoembryonic antigen (CEA), a widely used tumor marker, has been reported to be related with atherosclerosis and cardiovascular disease. However, little is known about the relationship between arterial stiffness and CEA level. We assessed whether serum CEA level is related with arterial stiffness by measuring brachial-ankle pulse wave velocity (ba-PWV) in healthy subjects.
METHODS: Serum CEA level, ba-PWV and conventional risk factors were measured in 2909 subjects (1767 men and 1142 women) who underwent routine health checkup. We performed correlation, multiple linear regression and multiple logistic regression analyses to divide into quartiles according to CEA level.
RESULTS: The mean values of ba-PWV increased gradually by CEA quartile. After correcting for significantly correlated variables, the ba-PWV was independently associated with CEA (P<0.001). The odds ratios (95% CI) for high ba-PWV (>75th percentile; men: 1518 cm/s, women: 1487 cm/s) according to CEA quartile were 1.00 (Q1), 1.044 (0.659-1.652; Q2), 1.075 (0.688-1.681; Q3), and 1.595 (1.009-2.520; Q4) after adjusting for age, blood pressure, BMI, fasting glucose, heart rate, log hs-CRP, LDL-cholesterol, WBC count, alcohol intake, smoking and exercise in men (P<0.001). The odds ratios (95% CIs) in women were 1.00 (Q1), 1.719 (0.971-3.032; Q2), 1.793 (1.019-3.156; Q3), and 2.330 (1.312-4.139; Q4) (P<0.001) after adjusting for age, blood pressure, BMI, fasting glucose, heart rate, log hs-CRP, lipid profile, uric acid, WBC count, alcohol intake, smoking and exercise.
CONCLUSIONS: The CEA level is associated with arterial stiffness which measured by ba-PWV in healthy Korean men and women. Crown
Copyright © 2012. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23159295     DOI: 10.1016/j.cca.2012.10.052

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Association between serum carcinoembryonic antigen level and oxidative stress parameters among diabetic females.

Authors:  Marghoob Hasan; Abdelmarouf Mohieldein
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Serum carcinoembryonic antigen is positively associated with leukocyte count in Korean adults.

Authors:  Yu-Jin Kwon; Hye-Sun Lee; Jae-Yong Shim; Yong-Jae Lee
Journal:  J Clin Lab Anal       Date:  2017-06-27       Impact factor: 2.352

3.  Gender-specific associations between apolipoprotein A1 and arterial stiffness in patients with nonalcoholic fatty liver disease.

Authors:  Xulong Sun; Ruifang Chen; Guangyu Yan; Zhiheng Chen; Hong Yuan; Wei Huang; Yao Lu
Journal:  PeerJ       Date:  2020-08-18       Impact factor: 2.984

4.  The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson's disease.

Authors:  Eşref Akıl; Aslıhan Bulut; İbrahim Kaplan; Hasan Hüseyin Özdemir; Demet Arslan; Mehmet Ufuk Aluçlu
Journal:  Neurol Sci       Date:  2014-10-07       Impact factor: 3.307

5.  The High Prevalence of Short-Term Elevation of Tumor Markers Due to Hyperglycemia in Diabetic Patients.

Authors:  Xi-Yu Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-11       Impact factor: 3.249

6.  High-normal serum carcinoembryonic antigen levels and increased risk of diabetic peripheral neuropathy in type 2 diabetes.

Authors:  Chun-Hua Wang; Chao Yu; Lei Zhuang; Feng Xu; Li-Hua Zhao; Xiao-Hua Wang; Li-Yan Ning; Xiu-Lin Zhang; Dong-Mei Zhang; Xue-Qin Wang; Jian-Bin Su
Journal:  Diabetol Metab Syndr       Date:  2022-09-27       Impact factor: 5.395

7.  Factors Associated with Serum Levels of Carcinoembryonic Antigen in Healthy Non-smokers.

Authors:  Jung-Im No; Jung-Yoon Yang; Han Jae Hyun; Choi Si Yeon; Hee-Jeong Choi
Journal:  Korean J Fam Med       Date:  2013-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.